Anti-FHL2 antibody [EPR17860-23]
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(2 Publications)
Rabbit Recombinant Monoclonal FHL2 antibody. Suitable for IP, WB, ICC/IF and reacts with Human, Mouse, Rat samples. Cited in 2 publications.
View Alternative Names
DRAL, SLIM3, FHL2, Four and a half LIM domains protein 2, FHL-2, LIM domain protein DRAL, Skeletal muscle LIM-protein 3, SLIM-3
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-FHL2 antibody [EPR17860-23] (AB202586)
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized A-673 (Human muscle Ewing's Sarcoma cell line) cells labeling FHL2 with ab202586 at 1/100 dilution, followed by Goat Anti-Rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/500 dilution (green). Confocal image showing cytoplasmic and weakly nuclear staining on A-673 cell line. The nuclear counter stain is DAPI (blue). Tubulin is detected with Anti-alpha Tubulin mouse MAb (ab7291) at 1/1000 dilution, followed by Goat Anti-Mouse IgG H&L (Alexa Fluor® 594) (ab150120) secondary antibody at 1/500 dilution (red).
The negative controls are as follows :
-ve control 1 : ab202586 at 1/100 dilution, followed by Goat Anti-Mouse IgG H&L (Alexa Fluor® 594) (ab150120) secondary antibody at 1/500 dilution.
-ve control 2 : Anti-alpha Tubulin mouse MAb (ab7291) at 1/1000 dilution, followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/500 dilution.
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-FHL2 antibody [EPR17860-23] (AB202586)
ab202586 staining FHL2 in wild-type U2OS cells (top panel) and FHL2 knockout U2OS cells (bottom panel). The cells were fixed with 4% PFA (10 min), permeabilized with 0.1% Triton X-100 for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1% PBS-Tween for 1h. The cells were then incubated with ab202586 at 1/100 dilution and ab7291 (Tubulin) at 1/1000 dilution overnight at +4°C, followed by a further incubation at room temperature for 1h with a goat secondary antibody to rabbit IgG (Alexa Fluor® 488) (ab150081) at 2 μg/ml (shown in green) and a goat secondary antibody to mouse IgG (Alexa Fluor® 594) (ab150120) at 2 μg/ml (shown in pseudo color red). Nuclear DNA was labelled in blue with DAPI.
Image was taken with a confocal microscope (Leica-Microsystems, TCS SP8).
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-FHL2 antibody [EPR17860-23] (AB202586)
ab202586 staining FHL2 in wild-type U2OS cells (top panel) and FHL2 knockout U2OS cells (bottom panel). The cells were fixed with 100% methanol (5 min), permeabilized with 0.1% Triton X-100 for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1% PBS-Tween for 1h. The cells were then incubated with ab202586 at 1/100 dilution and ab7291 (Tubulin) at 1/1000 dilution overnight at +4°C, followed by a further incubation at room temperature for 1h with a goat secondary antibody to rabbit IgG (Alexa Fluor® 488) (ab150081) at 2 μg/ml (shown in green) and a goat secondary antibody to mouse IgG (Alexa Fluor® 594) (ab150120) at 2 μg/ml (shown in pseudo color red). Nuclear DNA was labelled in blue with DAPI.
Image was taken with a confocal microscope (Leica-Microsystems, TCS SP8).
- IP
Supplier Data
Immunoprecipitation - Anti-FHL2 antibody [EPR17860-23] (AB202586)
FHL2 was immunoprecipitated from 1mg of SW480 (Human colorectal adenocarcinoma cell line) whole cell lysate with ab202586 at 1/20 dilution. Western blot was performed from the immunoprecipitate using ab202586 at 1/1000 dilution. Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG, was used as secondary antibody at 1/1500 dilution.
Lane 1 : SW480 whole cell lysate 10 μg (Input). Lane 2 : ab202586 IP in SW480 whole cell lysate. Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab202586 in SW480 whole cell lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 5 seconds.
All lanes:
Immunoprecipitation - Anti-FHL2 antibody [EPR17860-23] (ab202586)
Predicted band size: 32 kDa
false
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-FHL2 antibody [EPR17860-23] (AB202586)
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized NIH/3T3 (Mouse embyro fibroblast cells) cells labeling FHL2 with ab202586 at 1/100 dilution, followed by Goat Anti-Rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/500 dilution (green). Confocal image showing cytoplasmic and weakly nuclear staining on A-673 cell line. The nuclear counter stain is DAPI (blue). Tubulin is detected with Anti-alpha Tubulin mouse MAb (ab7291) at 1/1000 dilution, followed by Goat Anti-Mouse IgG H&L (Alexa Fluor® 594) (ab150120) secondary antibody at 1/500 dilution (red).
The negative controls are as follows :
-ve control 1 : ab202586 at 1/100 dilution, followed by Goat Anti-Mouse IgG H&L (Alexa Fluor® 594) (ab150120) secondary antibody at 1/500 dilution.
-ve control 2 : Anti-alpha Tubulin mouse MAb (ab7291) at 1/1000 dilution, followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/500 dilution.
- WB
Supplier Data
Western blot - Anti-FHL2 antibody [EPR17860-23] (AB202586)
5% NFDM/TBST : Blocking and diluting buffer.
All lanes:
Western blot - Anti-FHL2 antibody [EPR17860-23] (ab202586) at 1/2000 dilution
Lane 1:
SW480 (Human colorectal adenocarcinoma cell line) whole cell lysate at 10 µg
Lane 2:
PC-12 (Rat adrenal gland pheochromocytoma) whole cell lysate at 10 µg
Lane 3:
HT1080 (Human fibrosarcoma cells) whole cell lysate at 10 µg
Lane 4:
HeLa (Human epithelial cells from cervix adenocarcinoma) whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/1000 dilution
Predicted band size: 32 kDa
Observed band size: 32 kDa
false
Exposure time: 3min
- WB
Lab
Western blot - Anti-FHL2 antibody [EPR17860-23] (AB202586)
** Lanes 1-3 : ** Merged signal (red and green). Green - ab202586 observed at 32 kDa. Red - loading control ab7291 observed at 50 kDa. ab202586 Recombinant Anti-FHL2 antibody [EPR17860-23] was shown to specifically react with FHL2 in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab265475 (knockout cell lysate ab257441) was used. Wild-type and FHL2 knockout samples were subjected to SDS-PAGE. ab202586 and Anti-alpha Tubulin antibody [DM1A] - Loading Control (ab7291) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-FHL2 antibody [EPR17860-23] (ab202586) at 1/1000 dilution
Lane 1:
Wild-type HeLa lysate at 20 µg
Lane 2:
FHL2 knockout HeLa lysate at 20 µg
Lane 2:
Western blot - Human FHL2 knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-fhl2-knockout-hela-cell-line-ab265475'>ab265475</a>)
Lane 3:
K562 lysate at 20 µg
Predicted band size: 32 kDa
Observed band size: 32 kDa
false
- WB
Lab
Western blot - Anti-FHL2 antibody [EPR17860-23] (AB202586)
Lanes 1 - 3 : Merged signal (red and green). Green - ab202586 observed at 32 kDa. Red - loading control ab7291 (Mouse anti-Alpha Tubulin [DM1A] observed at 55kDa.
ab202586 was shown to react with FHL2 in wild-type U-2 OS cells in western blot with loss of signal observed in FHL2 knockout sample. Wild-type and FHL2 knockout U-2 OS cell lysates were subjected to SDS-PAGE. Membranes were blocked in 3% milk in TBS-T (0.1% Tween®) before incubation with ab202586 and ab7291 (Mouse anti-Alpha Tubulin [DM1A] overnight at 4°C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-FHL2 antibody [EPR17860-23] (ab202586) at 1/1000 dilution
Lane 1:
Wild-type U-2 OS cell lysate at 40 µg
Lane 2:
FHL2 knockout U-2 OS cell lysate at 40 µg
Lane 2:
Western blot - Human FHL2 knockout U-2 OS cell line (<a href='/en-us/products/cell-lines/human-fhl2-knockout-u-2-os-cell-line-ab262496'>ab262496</a>)
Lane 3:
HeLa cell lysate at 40 µg
Predicted band size: 32 kDa
Observed band size: 32 kDa
false
- WB
Supplier Data
Western blot - Anti-FHL2 antibody [EPR17860-23] (AB202586)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-FHL2 antibody [EPR17860-23] (ab202586) at 1/10000 dilution
All lanes:
Human fetal heart lysate at 10 µg
Secondary
All lanes:
Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1000 dilution
Predicted band size: 32 kDa
Observed band size: 32 kDa
false
Exposure time: 30s
- WB
Lab
Western blot - Anti-FHL2 antibody [EPR17860-23] (AB202586)
Lanes 1 - 3 : Merged signal (red and green). Green - ab202586 observed at 32 kDa. Red - loading control ab7291 (Mouse anti-Alpha Tubulin [DM1A] observed at 55kDa.
ab202586 was shown to react with FHL2 in wild-type U-2 OS cells in western blot with loss of signal observed in FHL2 knockout sample. Wild-type and FHL2 knockout U-2 OS cell lysates were subjected to SDS-PAGE. Membranes were blocked in 3% milk in TBS-T (0.1% Tween®) before incubation with ab202586 and ab7291 (Mouse anti-Alpha Tubulin [DM1A] overnight at 4°C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-FHL2 antibody [EPR17860-23] (ab202586) at 1/1000 dilution
Lane 1:
Wild-type U-2 OS cell lysate at 40 µg
Lane 2:
FHL2 knockout U-2 OS cell lysate at 40 µg
Lane 3:
HeLa cell lysate at 40 µg
Predicted band size: 32 kDa
false
- WB
Supplier Data
Western blot - Anti-FHL2 antibody [EPR17860-23] (AB202586)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-FHL2 antibody [EPR17860-23] (ab202586) at 1/10000 dilution
Lane 1:
Mouse heart lysate at 10 µg
Lane 2:
Mouse kidney lysate at 10 µg
Lane 3:
Rat heart lysate at 10 µg
Lane 4:
Rat kidney lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/1000 dilution
Predicted band size: 32 kDa
Observed band size: 32 kDa
false
Exposure time: 30s
Related conjugates and formulations (1)
-
Anti-FHL2 antibody [EPR17860-23] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The FHL2 protein serves critical functions in muscle development and differentiation. It operates as part of a multiprotein complex that interacts with cytoskeletal components contributing importantly to muscle cell adhesion and communication. Moreover FHL2 engages in transcriptional regulation and acts as a coactivator or corepressor of specific transcription factors influencing gene expression patterns relevant to muscle function and maintenance.
Pathways
The FHL2 protein plays significant roles in Wnt and MAPK signaling pathways. In the Wnt signaling pathway FHL2 regulates the transcriptional activity of beta-catenin an essential component of the pathway involved in cell growth and differentiation. Additionally FHL2 contributes to the MAPK signaling pathway by influencing interactions between upstream regulators and downstream targets modulating cellular responses to external stimuli. Through these pathways FHL2 interacts with various proteins including GATA4 and TEF-1 which are vital for its regulatory functions.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
American journal of physiology. Gastrointestinal and liver physiology 322:G234-G246 PubMed34941452
2021
Applications
Unspecified application
Species
Unspecified reactive species
Clinical proteomics 18:9 PubMed33618676
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com